MCP AbD Serotec
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2004.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M400160-MCP200v1
3/12/1200    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fach, E. M.
Right arrow Articles by Opiteck, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fach, E. M.
Right arrow Articles by Opiteck, G. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on October 12, 2004
Revised on October 20, 2004
Accepted on October 20, 2004

In vitro biomarker discovery for atherosclerosis by proteomics

Estelle M. Fach, Leah-Ann Garulacan, Ji Gao, Qing Xiao, Stephen M. Storm, Yves P. Dubaquie, Stanley A. Hefta, and Gregory J. Opiteck

Clinical Discovery Technologies, Bristol Myers Squibb, Pennington, NJ 08648

Corresponding Author: estelle.fach{at}bms.com

Summary Objective: The purpose of this study was to identify in vitro and then prioritize a tractable set of protein biomarker candidates of atherosclerosis that may eventually be developed to measure the extent, progression, regression and stability of atherosclerotic lesions. Methods and results: A study was conducted using an in vitro “foam cell” model based on the stimulation of differentiated THP1 cells with oxidized low density lipoprotein (oxidized LDL) as compared to low density lipoprotein (LDL). Analysis of the proteins contained in the cell supernatant using proteome scanning technology identified fifty-nine proteins as being increased, fifty-seven with no statistically measurable difference, and seventeen decreasing in abundance following treatment with oxidized LDL, as compared to LDL. From the upregulated list, proteins were prioritized based on their analytical confidence as well as their relevance to atherosclerosis pathways. Conclusions: Within the group of increased abundance, seven family of proteins were of particular interest: fatty acid-binding proteins, chitinase-like enzymes, cyclophilins, cathepsins, proteoglycans , urokinase–type plasminogen activator receptor and a macrophage scavenger receptor.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
A. V. G. Edwards, M. Y. White, and S. J. Cordwell
The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1824 - 1837.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman
Cathepsin cysteine proteases in cardiovascular disease
FASEB J, October 1, 2007; 21(12): 3029 - 3041.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. Bagnato, J. Thumar, V. Mayya, S.-I. Hwang, H. Zebroski, K. P. Claffey, C. Haudenschild, J. K. Eng, D. H. Lundgren, and D. K. Han
Proteomics Analysis of Human Coronary Atherosclerotic Plaque: A Feasibility Study of Direct Tissue Proteomics by Liquid Chromatography and Tandem Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2007; 6(6): 1088 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. M. Blanco-Colio, J. L. Martin-Ventura, F. Vivanco, J.-B. Michel, O. Meilhac, and J. Egido
Biology of atherosclerotic plaques: What we are learning from proteomic analysis
Cardiovasc Res, October 1, 2006; 72(1): 18 - 29.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. P. Conway and M. Kinter
Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1522 - 1540.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.